Adolescent Alopecia Areata

Adolescent Alopecia Areata

This trial is currently closed for enrollment.

adolescent alopecia areata

Skin Care Research is currently enrolling participants for an Adolescent Alopecia Areata clinical trial in Boca Raton, FL Hollywood, FL and Dallas, TX. Qualified participants will receive all study-related care provided by board-certified dermatologists at one of our partnered clinics. All Skin Care Research studies are in compliance with FDA guidelines and uphold the highest clinical standards.

To Qualify:

  • Must be 12 – 17 years old
  • Must have a diagnosis of alopecia areata for at least 1 year
  • Must have ≥50% hair loss (will be determined by the investigator)
  • Be willing to travel to one of our locations (transportation may be provided)

To learn more, fill out a form on this page or call 561-948-3116


Alopecia Areata Clinical Trials: What is Alopecia Areata?

Alopecia areata is a common autoimmune disorder that affects the hair follicles, leading to hair loss. It typically presents as patchy hair loss on the scalp, but it can also affect other areas of the body where hair is present, such as the eyebrows, eyelashes, beard, and body hair.

Alopecia areata can occur at any age, but it often starts in childhood or early adulthood. The condition can be unpredictable, with hair loss occurring suddenly and the regrowth of hair happening spontaneously. Some individuals may experience recurrent episodes of hair loss and regrowth, while others may have more extensive or persistent hair loss.

About Skin Care Research

As a clinical research center with over 25 years of experience in the execution of dermatological and cosmetic clinical trials, Skin Care Research has conducted hundreds of successful research studies for trusted brands including Abbvie, Eli Lilly, Galderma, Pfizer Inc, and more. Our research staff and board-certified dermatologists are highly trained and experienced in conducting FDA approved clinical trials.

Skin Care Research conducts phase 2 through phase 4 clinical trials with patient safety being the number one priority. To learn more about our enrolling studies, including time commitment, participant responsibilities, and other things you should expect, fill out the form or give us a call at 561-948-3116.